8 results
Algorithm for the Evaluation of Anemia #Diagnosis #EM #IM #Honc #Anemia #Differential #Workup #Algorithm #Microcytic #Macrocytic
Evaluation of Anemia ... Diagnosis #EM #IM ... #Honc #Anemia #Differential ... #Workup #Algorithm ... #Microcytic #Macrocytic
Evaluation of Patients with Anemia

Microcytic, Normocytic, Macrocytic, Hemolytic (Intravascular and Extravascular)

#Diagnosis #Anemia #Workup #Macrocytic #Microcytic #Normocytic
Evaluation of Patients ... Diagnosis #Anemia #Workup ... #Macrocytic #Microcytic ... #Normocytic #Differential ... #Algorithm
Laboratory Evaluation of Hypocalcemia #Diagnosis #EM #IM #Evaluation #Workup #Hypocalcemia #PTH #Differential #Algorithm #Ddxof
Laboratory Evaluation ... Diagnosis #EM #IM ... #Evaluation #Workup ... Hypocalcemia #PTH #Differential ... #Algorithm #Ddxof
Evaluation of Lymphadenopathy - Localized vs Generalized #Diagnosis #EM #IM #Honc #Lymphadenopathy #Localized #Generalized #Infectious #Malignancy
Evaluation of Lymphadenopathy ... Diagnosis #EM #IM ... Generalized #Infectious #Malignancy ... #Differential # ... Algorithm #Ddxof
Jaundice Evaluation Algorithm #Diagnosis #Management #EM #IM #GI #Jaundice #Hyperbilirubinemia #Workup #Evaluation #Differential #Algorithm #Direct #Indirect
Jaundice Evaluation ... Algorithm #Diagnosis ... Management #EM #IM ... Hyperbilirubinemia #Workup ... #Evaluation #Differential
Differential Diagnosis of Hypoglycemia
Evaluation of Hypoglycemia
Patients with known diabetes who are not systemically ill and can
Differential Diagnosis ... of Hypoglycemia Evaluation ... Diagnosis #EM #IM ... #Algorithm #Drugs ... #Malignancy #Exogenous
Hematuria Workup and Diagnosis Algorithm
 • Confirm hematuria → Urinalysis >3 RBCs/HPF, exclude mimics, repeat testing
Hematuria Workup ... and Diagnosis Algorithm ... biopsy • Risk factors ... for malignancy ... identified by UW IM
Causes of Secondary Hypertension - Workup and Differential Diagnosis
Approach (when evaluation should be done):
1. Severe or
Hypertension - Workup ... and Differential ... Approach (when evaluation ... no other risk factors ... Malignant or accelerated